Adicet Therapeutics
Clinical trials sponsored by Adicet Therapeutics, explained in plain language.
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called Prula-cel for people with certain autoimmune diseases like lupus and scleroderma. Prula-cel uses specially engineered immune cells from a healthy donor to target and attack faulty immune cells that cause disease. The main goals …
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
CAR t cell therapy: 15-Year safety check begins for lymphoma patients
Knowledge-focused OngoingThis study follows about 50 people who have already received an experimental CAR T cell therapy for certain types of lymphoma. The goal is to track any long-term side effects and survival for up to 15 years after treatment. No new study drug is given, but participants may receive…
Sponsor: Adicet Therapeutics • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC